Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,559 | 1,287 | 99.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.1% |
| Education | $12.35 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,305 | 229 | $0 (2024) |
| ABBVIE INC. | $1,914 | 173 | $0 (2024) |
| PFIZER INC. | $1,190 | 96 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,041 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $947.66 | 53 | $0 (2023) |
| Lilly USA, LLC | $890.80 | 92 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $709.72 | 40 | $0 (2022) |
| Amgen Inc. | $656.05 | 45 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $590.39 | 39 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $456.67 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,296 | 167 | ABBVIE INC. ($380.96) |
| 2023 | $2,843 | 193 | ABBVIE INC. ($380.48) |
| 2022 | $2,405 | 164 | Novo Nordisk Inc ($435.51) |
| 2021 | $2,547 | 181 | Novo Nordisk Inc ($351.58) |
| 2020 | $984.37 | 66 | Novo Nordisk Inc ($203.63) |
| 2019 | $2,143 | 169 | Novo Nordisk Inc ($304.86) |
| 2018 | $2,416 | 179 | PFIZER INC. ($281.73) |
| 2017 | $1,962 | 172 | SANOFI-AVENTIS U.S. LLC ($409.26) |
All Payment Transactions
1,291 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $4.30 | General |
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: Obesity | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.44 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,881 | 2,965 | $389,210 | $153,624 |
| 2022 | 18 | 1,658 | 2,329 | $310,388 | $122,305 |
| 2021 | 15 | 1,752 | 2,632 | $309,594 | $125,297 |
| 2020 | 27 | 2,135 | 3,165 | $352,048 | $119,862 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 360 | 893 | $188,696 | $70,230 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 259 | 259 | $57,699 | $31,110 | 53.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 126 | 140 | $40,400 | $14,593 | 36.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 70 | 190 | $19,380 | $8,693 | 44.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 30 | 30 | $9,840 | $4,653 | 47.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 61 | 61 | $11,285 | $4,312 | 38.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 249 | 343 | $4,013 | $2,851 | 71.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $5,760 | $2,784 | 48.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $6,059 | $2,588 | 42.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 61 | $2,135 | $1,765 | 82.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 111 | 177 | $7,788 | $1,677 | 21.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 36 | $5,148 | $1,284 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $3,192 | $985.10 | 30.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 135 | 143 | $3,575 | $896.20 | 25.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 26 | $2,990 | $883.00 | 29.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 89 | $4,272 | $858.10 | 20.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 99 | 100 | $6,511 | $856.80 | 13.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 12 | 22 | $2,464 | $764.05 | 31.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 87 | 92 | $2,852 | $700.12 | 24.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 21 | $1,995 | $388.03 | 19.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 11 | $1,298 | $321.86 | 24.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 16 | 16 | $704.00 | $218.72 | 31.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 32 | 49 | $686.00 | $152.39 | 22.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 92 | $460.00 | $57.66 | 12.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 57 | $7.56 | $1.54 | 20.4% |
About Dr. Eric Faile, M.D
Dr. Eric Faile, M.D is a Family Medicine healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942247382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Faile, M.D has received a total of $17,596 in payments from pharmaceutical and medical device companies, with $2,296 received in 2024. These payments were reported across 1,291 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($17,559).
As a Medicare-enrolled provider, Faile has provided services to 7,426 Medicare beneficiaries, totaling 11,091 services with total Medicare billing of $521,088. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Greenville, SC
- Active Since 06/02/2006
- Last Updated 05/22/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1942247382
Products in Payments
- Ozempic (Drug) $919.07
- VRAYLAR (Drug) $725.21
- NURTEC ODT (Drug) $720.75
- XARELTO (Drug) $677.81
- REXULTI (Drug) $538.71
- FARXIGA (Drug) $530.07
- TOUJEO (Drug) $438.23
- XIFAXAN (Drug) $409.43
- UBRELVY (Drug) $354.49
- Synthroid (Drug) $351.41
- Aimovig (Biological) $331.95
- Cologuard Collection Kit (Device) $323.75
- ELIQUIS (Drug) $318.46
- CHANTIX (Drug) $313.04
- TRINTELLIX (Drug) $312.61
- MOUNJARO (Drug) $302.71
- Tresiba (Drug) $301.03
- Victoza (Drug) $295.31
- QULIPTA (Drug) $286.91
- Trintellix (Drug) $267.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greenville
James Franklin, M.d, M.D
Family Medicine — Payments: $114,754
Jeffrey Harris, Md, MD
Family Medicine — Payments: $112,265
Steve Hamberis, M.d, M.D
Family Medicine — Payments: $23,679
Dr. Richard Leland, M.d, M.D
Family Medicine — Payments: $22,628
Dr. Quentin Mewborn, Md, MD
Family Medicine — Payments: $17,870
Saria Saccocio, Md, MD
Family Medicine — Payments: $17,308